The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Atovaquone-Global Market Insights and Sales Trends 2025
Synopsis
Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.
The global Atovaquone market size is expected to reach US$ 282.6 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Atovaquone in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Atovaquone market. 250mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 500mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Atovaquone market, driven by demand from China, the second largest economy with some signs of stabilising, the Atovaquone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atovaquone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atovaquone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atovaquone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atovaquone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atovaquone covered in this report include GSK, Lupin, Apotex and Amneal Pharmaceuticals, etc.
The global Atovaquone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Lupin
Apotex
Amneal Pharmaceuticals
Global Atovaquone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atovaquone market, Segment by Type:
250mg
500mg
Global Atovaquone market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atovaquone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atovaquone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.
The global Atovaquone market size is expected to reach US$ 282.6 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Atovaquone in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Atovaquone market. 250mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 500mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Atovaquone market, driven by demand from China, the second largest economy with some signs of stabilising, the Atovaquone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atovaquone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atovaquone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atovaquone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atovaquone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atovaquone covered in this report include GSK, Lupin, Apotex and Amneal Pharmaceuticals, etc.
The global Atovaquone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Lupin
Apotex
Amneal Pharmaceuticals
Global Atovaquone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atovaquone market, Segment by Type:
250mg
500mg
Global Atovaquone market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atovaquone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atovaquone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Atovaquone Market Overview
1.1 Atovaquone Product Overview
1.2 Atovaquone Market Segment by Type
1.2.1 250mg
1.2.2 500mg
1.3 Global Atovaquone Market Size by Type
1.3.1 Global Atovaquone Market Size Overview by Type (2018-2029)
1.3.2 Global Atovaquone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Atovaquone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Atovaquone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Atovaquone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Atovaquone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Atovaquone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Atovaquone Sales Breakdown by Type (2018-2023)
2 Global Atovaquone Market Competition by Company
2.1 Global Top Players by Atovaquone Sales (2018-2023)
2.2 Global Top Players by Atovaquone Revenue (2018-2023)
2.3 Global Top Players by Atovaquone Price (2018-2023)
2.4 Global Top Manufacturers Atovaquone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Atovaquone Market Competitive Situation and Trends
2.5.1 Atovaquone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Atovaquone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atovaquone as of 2022)
2.7 Date of Key Manufacturers Enter into Atovaquone Market
2.8 Key Manufacturers Atovaquone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Atovaquone Status and Outlook by Region
3.1 Global Atovaquone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Atovaquone Historic Market Size by Region
3.2.1 Global Atovaquone Sales in Volume by Region (2018-2023)
3.2.2 Global Atovaquone Sales in Value by Region (2018-2023)
3.2.3 Global Atovaquone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Atovaquone Forecasted Market Size by Region
3.3.1 Global Atovaquone Sales in Volume by Region (2024-2029)
3.3.2 Global Atovaquone Sales in Value by Region (2024-2029)
3.3.3 Global Atovaquone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Atovaquone by Application
4.1 Atovaquone Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Atovaquone Market Size by Application
4.2.1 Global Atovaquone Market Size Overview by Application (2018-2029)
4.2.2 Global Atovaquone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Atovaquone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Atovaquone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Atovaquone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Atovaquone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Atovaquone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Atovaquone Sales Breakdown by Application (2018-2023)
5 North America Atovaquone by Country
5.1 North America Atovaquone Historic Market Size by Country
5.1.1 North America Atovaquone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Atovaquone Sales in Volume by Country (2018-2023)
5.1.3 North America Atovaquone Sales in Value by Country (2018-2023)
5.2 North America Atovaquone Forecasted Market Size by Country
5.2.1 North America Atovaquone Sales in Volume by Country (2024-2029)
5.2.2 North America Atovaquone Sales in Value by Country (2024-2029)
6 Europe Atovaquone by Country
6.1 Europe Atovaquone Historic Market Size by Country
6.1.1 Europe Atovaquone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Atovaquone Sales in Volume by Country (2018-2023)
6.1.3 Europe Atovaquone Sales in Value by Country (2018-2023)
6.2 Europe Atovaquone Forecasted Market Size by Country
6.2.1 Europe Atovaquone Sales in Volume by Country (2024-2029)
6.2.2 Europe Atovaquone Sales in Value by Country (2024-2029)
7 Asia-Pacific Atovaquone by Region
7.1 Asia-Pacific Atovaquone Historic Market Size by Region
7.1.1 Asia-Pacific Atovaquone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Atovaquone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Atovaquone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Atovaquone Forecasted Market Size by Region
7.2.1 Asia-Pacific Atovaquone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Atovaquone Sales in Value by Region (2024-2029)
8 Latin America Atovaquone by Country
8.1 Latin America Atovaquone Historic Market Size by Country
8.1.1 Latin America Atovaquone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Atovaquone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Atovaquone Sales in Value by Country (2018-2023)
8.2 Latin America Atovaquone Forecasted Market Size by Country
8.2.1 Latin America Atovaquone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Atovaquone Sales in Value by Country (2024-2029)
9 Middle East and Africa Atovaquone by Country
9.1 Middle East and Africa Atovaquone Historic Market Size by Country
9.1.1 Middle East and Africa Atovaquone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Atovaquone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Atovaquone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Atovaquone Forecasted Market Size by Country
9.2.1 Middle East and Africa Atovaquone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Atovaquone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Atovaquone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Atovaquone Products Offered
10.1.5 GSK Recent Development
10.2 Lupin
10.2.1 Lupin Company Information
10.2.2 Lupin Introduction and Business Overview
10.2.3 Lupin Atovaquone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Lupin Atovaquone Products Offered
10.2.5 Lupin Recent Development
10.3 Apotex
10.3.1 Apotex Company Information
10.3.2 Apotex Introduction and Business Overview
10.3.3 Apotex Atovaquone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Apotex Atovaquone Products Offered
10.3.5 Apotex Recent Development
10.4 Amneal Pharmaceuticals
10.4.1 Amneal Pharmaceuticals Company Information
10.4.2 Amneal Pharmaceuticals Introduction and Business Overview
10.4.3 Amneal Pharmaceuticals Atovaquone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Amneal Pharmaceuticals Atovaquone Products Offered
10.4.5 Amneal Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Atovaquone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Atovaquone Industrial Chain Analysis
11.4 Atovaquone Market Dynamics
11.4.1 Atovaquone Industry Trends
11.4.2 Atovaquone Market Drivers
11.4.3 Atovaquone Market Challenges
11.4.4 Atovaquone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Atovaquone Distributors
12.3 Atovaquone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
